Medical Parasitology and Infection Biology
MPI NewsAll News
A new study reveals that it is possible to identify those individuals that will be protected by the malaria vaccine before its administration. The researchers also found that... More...
"It Is a Race Against Time." An Interview with Claudia Daubenberger on Establishing a Diagnostic Lab for Sars-CoV-2 in Equatorial Guinea
COVID-19 poses major challenges for resource-limited countries, also when it comes to diagnostics. Swiss TPH is supporting Equatorial Guinea in establishing one of the few... More...
In low- and middle-income countries, children have the greatest need for protection afforded by vaccination due to a higher incidence of infectious diseases. However, the vaccines... More...
Latest MPI PublicationsAll Publications
Brunetti G et al. Nanotechnological immunoassay for rapid label-free analysis of candidate malaria vaccines. Nanoscale. 2021;in press. DOI: 10.1039/D0NR08083G
Cheuka P.M et al. New amidated 3,6-diphenylated imidazopyridazines with potent antiplasmodium activity are dual inhibitors of Plasmodium phosphatidylinositol-4-kinase and cGMP-dependent protein kinase. ACS Infect Dis. 2021;7(1):34-46. DOI: 10.1021/acsinfecdis.0c00481
Diakité N.R et al. Baseline and impact of first-year intervention on Schistosoma haematobium infection in seasonal transmission foci in the northern and central parts of Côte d’Ivoire. Trop Med Infect Dis. 2021;6:7. DOI: 10.3390/tropicalmed6010007
Jongo S.A et al. Immunogenicity and protective efficacy of radiation-attenuated and chemo-attenuated PfSPZ vaccines in Equatoguinean adults. Am J Trop Med Hyg. 2021;104(1):283-293. DOI: 10.4269/ajtmh.20-0435
Keiser J, Häberli C. Evaluation of commercially available anthelminthics in laboratory models of human intestinal nematode infections. ACS Infect Dis. 2021(in press). DOI: 10.1021/acsinfecdis.0c00719